Preneoplastic mammary tumor markers: Cripto and amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice
暂无分享,去创建一个
[1] E. Adamson,et al. Cripto: roles in mammary cell growth, survival, differentiation and transformation , 1998, Cell Death and Differentiation.
[2] R. Dickson,et al. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[3] D. Salomon,et al. Detection of amphiregulin and Cripto‐1 in mammary tumors from transgenic mice , 1996, Molecular carcinogenesis.
[4] R. Sharp,et al. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. , 1995, The American journal of pathology.
[5] D. Salomon,et al. Detection and location of amphiregulin and Cripto‐1 expression in the developing postnatal mouse mammary gland , 1995, Molecular reproduction and development.
[6] N. Hynes,et al. The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.
[7] R. Coffey,et al. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. , 1994, The Journal of biological chemistry.
[8] N. Normanno,et al. Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. , 1994, The Journal of biological chemistry.
[9] G. Merlo,et al. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.
[10] N. Normanno,et al. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Shoyab,et al. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. , 1993, The Journal of biological chemistry.
[12] R. Cardiff,et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Salomon,et al. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon , 1992, The Journal of cell biology.
[14] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[15] J G Klijn,et al. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.
[16] G. Merlino,et al. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.
[17] C R King,et al. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. , 1985, Science.
[18] R. Weinberg,et al. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen , 1984, Nature.
[19] S. Cohen,et al. Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver. , 1982, Proceedings of the National Academy of Sciences of the United States of America.